BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15135315)

  • 1. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
    Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME
    Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxins.
    Pentón D; Pérez-Barzaga V; Díaz I; Reytor ML; Campos J; Fando R; Calvo L; Cilli EM; Morera V; Castellanos-Serra LR; Pazos F; Lanio ME; Alvarez C; Pons T; Tejuca M
    Protein Eng Des Sel; 2011 Jun; 24(6):485-93. PubMed ID: 21296830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
    Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
    Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.
    Chow LP; Chang KH; Lin JY
    Biochem Int; 1990 Oct; 22(1):95-102. PubMed ID: 1704234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
    Griffin TW; Childs LR; FitzGerald DJ; Levin LV
    J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
    Liu XY; Zhen YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
    Doronina SO; Toki BE; Torgov MY; Mendelsohn BA; Cerveny CG; Chace DF; DeBlanc RL; Gearing RP; Bovee TD; Siegall CB; Francisco JA; Wahl AF; Meyer DL; Senter PD
    Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin.
    Avila AD; Calderón CF; Pérez RM; Pons C; Pereda CM; Ortiz AR
    Biol Res; 2007; 40(2):173-83. PubMed ID: 18064354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and characterization of human colon tumor-associated antigen and its clinical significance].
    Liu XY; Yao XL; Song Y; Liu XY; Zhang P; Xu ZS; Song LH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):335-7. PubMed ID: 17428389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell targeting of a pore-forming toxin, CytA delta-endotoxin from Bacillus thuringiensis subspecies israelensis, by conjugating CytA with anti-Thy 1 monoclonal antibodies and insulin.
    al-yahyaee SA; Ellar DJ
    Bioconjug Chem; 1996; 7(4):451-60. PubMed ID: 8853459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sticholysin II: a pore-forming toxin as a probe to recognize sphingomyelin in artificial and cellular membranes.
    Garcia PS; Chieppa G; Desideri A; Cannata S; Romano E; Luly P; Rufini S
    Toxicon; 2012 Oct; 60(5):724-33. PubMed ID: 22677808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytotoxic monoclonal antibody to colon adenocarcinoma.
    Kaszubowski PA; Terasaki PI; Chia DS; Kukes GD; Hardiwidjaja SI; Cicciarelli JC
    Cancer Res; 1984 Mar; 44(3):1194-9. PubMed ID: 6362858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.
    Shih LB; Goldenberg DM; Xuan H; Lu H; Sharkey RM; Hall TC
    Cancer Res; 1991 Aug; 51(16):4192-8. PubMed ID: 1868440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin.
    Avila AD; Mateo de Acosta C; Lage A
    Int J Cancer; 1989 May; 43(5):926-9. PubMed ID: 2785509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved purification and enzymatic properties of a mixture of Sticholysin I and II: isotoxins with hemolytic and phospholipase A(2) activities from the sea anemone Stichodactyla helianthus.
    del Monte-Martínez A; González-Bacerio J; Romero L; Aragón C; Martínez D; de Los Á Chávez M; Álvarez C; Lanio ME; Guisán JM; Díaz J
    Protein Expr Purif; 2014 Mar; 95():57-66. PubMed ID: 24326193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.
    Boghaert ER; Sridharan L; Armellino DC; Khandke KM; DiJoseph JF; Kunz A; Dougher MM; Jiang F; Kalyandrug LB; Hamann PR; Frost P; Damle NK
    Clin Cancer Res; 2004 Jul; 10(13):4538-49. PubMed ID: 15240546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.